Scholarlink

Background <p>Congenital heart diseases (CHDs) represent a significant healthcare challenge with incidence rates of 17.9 per 1000 live births. Extracorporeal membrane oxygenation (ECMO) has become an invaluable therapeutic option providing essential aid to support both cardiac as well as pulmonary failure. </p> Methods <p>A systematic search was performed using PubMed, Embase, and Scopus from 2000 till date. Observational studies involving pediatric patients with CHD undergoing cardiac surgery using ECMO were included. The main outcomes were to determine short-term mortality, weaning off ECMO, complications, hospital and ICU length of stay, and indications&#xa0;for&#xa0;ECMO. Assessment of the risk of bias of included studies was done by Newcastle–Ottawa scale. </p> Results <p>24 retrospective observational studies, encompassing 1,658 patients, were ultimately included in our review. The overall incidence of mortality across these studies was 45.2%. Successful weaning from ECMO was achieved in 73.9% of patients. The most frequently reported complications included bleeding, which affected 42.9% of patients, renal failure in 42.5%, and sepsis in 27.5%. The mean duration of hospital stay was 47.8 ± 41.1&#xa0;days, while the mean length of stay in the ICU was 33.4 ± 32.6&#xa0;days. </p> Conclusions <p>ECMO benefits pediatric heart patients but comes with risks like bleeding and high mortality. Percutaneous techniques can reduce complications; more research on minimally invasive approaches&#xa0;is&#xa0;needed.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Importance of extracorporeal membrane oxygenation (ECMO) in congenital heart diseases: a systematic review

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月11日

查看全文
  • Muhammad Shaheer Bin Faheem,
  • Ahmed Ali Khan,
  • Shamikha Cheema,
  • Muzamil Akhtar,
  • Danish Ali Ashraf

摘要

Background

Congenital heart diseases (CHDs) represent a significant healthcare challenge with incidence rates of 17.9 per 1000 live births. Extracorporeal membrane oxygenation (ECMO) has become an invaluable therapeutic option providing essential aid to support both cardiac as well as pulmonary failure.

Methods

A systematic search was performed using PubMed, Embase, and Scopus from 2000 till date. Observational studies involving pediatric patients with CHD undergoing cardiac surgery using ECMO were included. The main outcomes were to determine short-term mortality, weaning off ECMO, complications, hospital and ICU length of stay, and indications for ECMO. Assessment of the risk of bias of included studies was done by Newcastle–Ottawa scale.

Results

24 retrospective observational studies, encompassing 1,658 patients, were ultimately included in our review. The overall incidence of mortality across these studies was 45.2%. Successful weaning from ECMO was achieved in 73.9% of patients. The most frequently reported complications included bleeding, which affected 42.9% of patients, renal failure in 42.5%, and sepsis in 27.5%. The mean duration of hospital stay was 47.8 ± 41.1 days, while the mean length of stay in the ICU was 33.4 ± 32.6 days.

Conclusions

ECMO benefits pediatric heart patients but comes with risks like bleeding and high mortality. Percutaneous techniques can reduce complications; more research on minimally invasive approaches is needed.